Current Study: PH2

Purpose:
• To determine how the investigational drug is absorbed, broken down, and removed from the body in volunteers with kidney impairment when compared to volunteers with a normal level of kidney function.
• Information regarding safety and side effects that may occur will also be collected.
• This study is for research purposes only and is not intended to treat your kidney disease.

Method of Administration: Single oral dose of study medication

Investigator: Thomas Marbury, MD

To qualify:

• 18 to 65 years old
• Must have kidney impairment or disease
• May be seeing a nephrologist, have reduced kidney function, or low creatinine clearance and taking medicine such as:

• Procrit®, Epogen®, or Aranesp® for low blood count
or
• PhosLo for high blood phosphorus

Length/Duration:
• 5 days and 4 nights in our research facility

Location 5055 South Orange Avenue, Orlando, FL 32809

Compensation Qualified participants will receive study medication, study related physical exams and laboratory tests

Qualified participants will be compensated up to $2,000 for time and travel

Whom to Contact Recruitment Department: 407-240-7876